Maryland Life Sciences
Maryland at BIO
Get to Know Maryland.
Maryland has its very own ecosystem of life sciences companies, making the state an impressive hub for scientific innovation. Maryland's life sciences industry not only stands out among other states, but also shines internationally. Our team, along with a delegation of Maryland companies, will represent Maryland at the BIO International Convention on June 5-8. Visit the Commerce team at Booth No. 3347 to see what Maryland offers businesses. Below, you can learn more about the leaders behind some life sciences companies that proudly call Maryland home and find their direct contact info for those interested in partnering.
The Maryland Delegation
COMPANIES EXHIBITING AT BIO INTERNATIONAL
These companies are exhibiting in the Maryland pavilion at the BIO International Convention. Scroll below for full company profiles.
Develops artificial immune systems that are inhaled and variant-proof by using encrypted RNA™, a new class of RNA.
A digital healthcare company formed with the goal to change the way medical professionals communicate, make decisions, and involve patients in the process.
A regulation consultation company that provides comprehensive strategy and operation services to guide clients through every step of the regulatory process.
Helps emerging market vaccine manufacturers learn how to make affordable conjugate vaccines and offers a variety of bioconjugation and protein services.
A biologics company developing novel therapeutics for unmet medical needs in metastatic castration-resistant prostate cancer, NASH liver fibrosis, and type 2 diabetes.
A biotech and contract research organization that employs a uniquely tailored approach to clients' specific testing needs.
A biotech research company developing the next generation of cancer vaccines.
A pre-clinical biotech therapeutic company redefining future emergency treatment for victims of traumatic blood loss.
The subsidiary company, PrimoCure Pharma, performs clinical studies, research, and development on anticancer therapeutics for KoDiscovery.
An advanced biomaterials company specializing in custom biopolymers for treating bleeding and managing wounds.
An immunotherapy company with the focus on solid tumor cancers.
OpenDNA is an AI precision medicine platform that analyzes patients' genetic data to predict and recommend treatment of chronic diseases.
A health company dedicated to bringing the next-generation solutions for treatment and early diagnosis of chronic and fatal diseases.
A culturally responsive behavioral health platform designed by and for BIPOC individuals and communities.
A clinical-stage biotech company developing a novel biopharmaceutical to treat and prevent respiratory diseases.
Develops artificial immune systems that are inhaled and variant-proof by using encrypted RNA™, a new class of RNA.
A digital healthcare company formed with the goal to change the way medical professionals communicate, make decisions, and involve patients in the process.
A regulation consultation company that provides comprehensive strategy and operation services to guide clients through every step of the regulatory process.
Helps emerging market vaccine manufacturers learn how to make affordable conjugate vaccines and offers a variety of bioconjugation and protein services.
A biologics company developing novel therapeutics for unmet medical needs in metastatic castration-resistant prostate cancer, NASH liver fibrosis, and type 2 diabetes.
A biotech and contract research organization that employs a uniquely tailored approach to clients' specific testing needs.
A biotech research company developing the next generation of cancer vaccines.
A pre-clinical biotech therapeutic company redefining future emergency treatment for victims of traumatic blood loss.
The subsidiary company, PrimoCure Pharma, performs clinical studies, research, and development on anticancer therapeutics for KoDiscovery.
An advanced biomaterials company specializing in custom biopolymers for treating bleeding and managing wounds.
An immunotherapy company with the focus on solid tumor cancers.
OpenDNA is an AI precision medicine platform that analyzes patients' genetic data to predict and recommend treatment of chronic diseases.
A health company dedicated to bringing the next-generation solutions for treatment and early diagnosis of chronic and fatal diseases.
A culturally responsive behavioral health platform designed by and for BIPOC individuals and communities.
A clinical-stage biotech company developing a novel biopharmaceutical to treat and prevent respiratory diseases.
#3
Technology and science workforce
#1
Federal obligations for R&D
2x
Federal labs than any other state
#5
Highest concentration doctoral scientists and engineers.
Autonomous Therapeutics, Inc.
Rockville, Maryland
Autonomous Therapeutics is a synthetic immunology company engineering artificial immune systems that are resistance-proof through the development of a new class of RNA, Encrypted RNA™.
The company's encrypted RNA platform technology can detect and eliminate any variant of a viral pathogen to enable resistance-proof immunity. The platform can also control the expression of any therapeutic protein.
Contact:
Ariel Weinberger, CEO & Founder
Avident Health LLC
Baltimore, Maryland
Avident Health is a digital healthcare company dedicated to improving the quality of care and efficiency in the healthcare industry.
The company focuses on increasing patients' engagement in their own care through implementing better coordination, transparency, and communication between physicians and their patients. Avident Health has two HIPAA-compliant cybersecurity-tested mobile apps available to help with their holistic approach.
Contact:
Maen Farha, Founder & Managing Partner
BLA Regulatory
Gaithersburg, Maryland
BLA Regulatory was named one of the Top 10 Emerging Consulting Companies in the biopharma industry in 2022 by Life Sciences Review.
BLA Regulatory creates a tailored approach based on the product and company needs to help move the product efficiently through the drug development cycle. The company offers services from product research, nonclinical, and clinical development, all the way up to the submission, approval, and the maintenance stage.
Contact:
Frank Li, Founder
Fina Biosolutions LLC
Rockville, Maryland
For over 15 years, Fina Biosolutions has been providing conjugate vaccine laboratory and consulting services for the global biotech and vaccine industry. The company specializes in conjugation chemistry, bioconjugation, and conjugate vaccines.
Fina Biosolutions has a well-equipped lab and its scientists collaborate with top universities and the local biotech community to expand resources.
Contact:
Andrew Lees, CEO
GlycoMantra
Halethorpe, Maryland
GlycoMantra is a startup biotech firm leading the translational glycobiology research and interested in the development of carbohydrate-based therapeutics of cancer, fibrosis, and diabetes.
The firm has developed a few high-affinity galectin-3 antagonists useful for various indications. GlycoMantra's CAR-T asset is based on a new concept of personalized "off-the-shelf" cellular immunotherapy for kidney cancer. The other asset is a small molecule drug for metastatic colorectal cancer.
Contact:
Hafiz Ahmed, President & CEO
Integrated Pharma Services
Rockville, Maryland
Integrated Pharma Services (IPS) is a biotechnology and contract research organization.
The organization is made up of scientists with over 75 years of experience. IPS has fully-equipped labs set up for experiments with live microorganisms ranging from small to billion-dollar companies. The organization offers antiviral testing, antimicrobial efficacy testing, bacterial recovery testing, and COVID-19 testing and validation.
Contact:
Mina Izadjoo, President & CSO
Irazu Oncology, LLC
Baltimore, Maryland
Irazu Oncology is a biotechnology research company with the mission to develop a superior vaccine platform to improve clinical outcomes for cancer patients.
The company's vaccine platform is flexible, cost effective, and can be applied to various tumor types. Irazu's Membrane Vesicle Platform (MVP) Technology uses Outer Membrane Vesicles (OMVs) as cancer vaccines.
Contact:
Bradley Cawthern, Director of Operations & Administration
KaloCyte, Inc.
Baltimore, Maryland
KaloCyte is a pre-clinical biotech therapeutic company redefining future emergency treatment for victims of traumatic blood loss. The company combined its founders' expertise in red blood cell physiology, trauma care, transfusion medicine, and nanotechnology to create a product called ErythroMer.
ErythroMer is a bioengineered artificial red blood cell substitute which can be freeze-dried for long-term storage, making it useful for pre-hospital treatment of traumatic hemorrhages when stored blood is unavailable, undesirable, or in short supply.
Contact:
Elaine Haynes, President & CEO
KoDiscovery, LLC. / PrimoCure Pharma, Inc.
Baltimore, Maryland
KoDiscovery's subsidiary company, PrimoCure Pharma has been supporting the development and expansion of its founder and CEO, Dr. Ko. Dr. Ko discovered the 3-Bromopyruvate's (3BP) ability to stop the cancer metabolism. The patented formulation utilizing 3BP is called KoDiscovery Anticancer Technology (KAT).
Since the company's start in 2012, PrimoCure Pharma has been an important partner in furthering the work of KAT and moving it along for FDA approvals.
Contact:
Young Ko, Founder
Medcura, Inc.
Riverdale, Maryland
Medcura is a biomaterials company that designs products for wound treatment and bleeding management. The company's products utilize a hydrophobically modified chitosan that has antimicrobial properties. The materials conform to bleeding tissue and contain no-swell properties.
Medcura's products come in a variety of forms and can be used in various instances, such as surgical bleeds, routine lacerations, nosebleeds, and traumatic injuries.
Contact:
Matthew Dowling, CSO
MedGene Therapeutics, Inc.
Gaithersburg, Maryland
MedGene Therapeutics is an immunotherapy company developing two breakthrough cell therapies targeting solid tumors. The two therapies used together in treatment is called AUTO-T™ therapy.
The first is a version of Tumor Infiltrating Lymphocyte therapy, PBL-T™, that is based on obtaining anti-cancer T cells through blood rather than tumor tissue. The other cell therapy is an anti-T cell exhaustion protocol, RIV-8™, which prevents and reverses persistent fading of T cell anti-tumor activity in patients.
Contact:
Yong Park, CEO
OpenDNA LLC.
Gaithersburg, Maryland
OpenDNA is a medicine platform using genomic AI to predict and prevent chronic diseases, specifically heart disease. The company's CardioRisk+ uses genetic testing with proprietary machine learning algorithms to give risk predictions and treatment recommendations. The results are presented in interactive reports that are easy for physicians and patients to engage with.
OpenDNA's technology allows for heart attack predictions with up to 85% accuracy.
Contact:
Nir Gamliel, CBO
PRECISION THERANOSTICS INC
Baltimore, Maryland
PRECISION THERANOSTICS (PTNx) is focused on the development of novel diagnostics, therapeutics, and prognosis based therapies for improving survival and finding cures for chronic respiratory diseases and age-related disorders.
The company's current theranostic pipeline includes novel intervention strategies for COPD-emphysema, Cystic Fibrosis, IPF, and age-related disorders. PTNx also has a track record of proof of concept (POC) peer-reviewed scientific publications that allow for further clinical development and innovation.
Contact:
Neeraj Vij, President & CEO
Sanitas Health, Inc.
Baltimore, Maryland
Sanitas is a culturally-responsive psychology-based language analysis platform for understanding human emotions, personalities, motivations, and psychology from everyday language. The platform allows users to engage with peers who share similar backgrounds and experiences while having the ability to stay anonymous and retain control of their information.
Sanitas partners with healthcare payers and providers to offer culturally responsive healthcare services through the format of support groups and 1-on-1 coaching over text messaging. Its services are available 24 hours a day, 7 days a week.
Contact:
Rodney Bell, Co-Founder & CEO
Trove Therapeutics, Inc.
Frederick, Maryland
Trove Therapeutics is a clinical-stage biopharmaceutical company developing a novel therapeutic protein called Therabron™ to address neglected and underrated respiratory conditions.
Trove is developing three products using different formulations of Therabron™ with varying ways to administer it for respiratory diseases that impact people of all ages.
Contact:
Aprile Pilon, CEO
